Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
Montreal Heart Institute
Montreal, CanadáPublicacións en colaboración con investigadores/as de Montreal Heart Institute (11)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
2022
-
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)
Nature Communications
-
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility
Nature Genetics, Vol. 54, Núm. 9, pp. 1275-1283
2020
-
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
Nature Communications, Vol. 11, Núm. 1
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
2015
2012
-
Vorapaxar in the secondary prevention of atherothrombotic events
New England Journal of Medicine, Vol. 366, Núm. 15, pp. 1404-1413